MARKET

PHIOW

PHIO PHARMACTCL
PHIOW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0572
0.5088
0.0124
-
Phio Pharmaceuticals to Present at DealFlow Discovery Conference in Atlantic City
Reuters · 01/26 13:15
PHIO PHARMACEUTICALS CORP - ANNOUNCES KEY TUMOR RESPONSE DATA FROM PH-762 TRIAL - SEC FILING
Reuters · 01/20 14:33
PHIO PHARMACEUTICALS CORP: SAFETY DATA THROUGH EXTENDED FOLLOW-UP PERIOD IS EXPECTED TO BE REPORTED IN Q2 OF 2026
Reuters · 01/20 14:33
Phio Pharmaceuticals Reports 70% Response Rate in PH-762 Skin Cancer Trial
Reuters · 01/20 14:31
Phio Pharmaceuticals Showcases INTASYL siRNA Cancer Therapy at Sidoti Micro-Cap Virtual Investor Conference
Reuters · 01/15 13:45
Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares
Reuters · 01/02 21:06
Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares
Reuters · 12/29/2025 13:10
PHIO PHARMACEUTICALS CORP - NO DOSE-LIMITING TOXICITIES IN PH-762 TRIAL - SEC FILING
Reuters · 12/23/2025 13:53
More

Webull offers PHIO PHARMACTCL stock information, including NASDAQ: PHIOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHIOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHIOW stock methods without spending real money on the virtual paper trading platform.